Health
Oxford University weighing up how vaccine platform would need to adapt to deal with variants – BioPharma-Reporter.com
The team behind the Oxford-AstraZeneca COVID-19 vaccine says it is carefully assessing the impact of new variants from the UK, South Africa and Brazil on vaccine…
It is known that viruses constantly change through mutation, leading to the emergence of new variants, and we should expect many new variants to be identified during 2021.
These changes are being monitored closely by scientists, and it is important we continue to remain vigilant for changes in the future.
The University of Oxford is evaluating the processes needed for rapid development of adjusted COVID-19 vaccines if these should be necessary, a strategic communications manager at the public…
-
Business17 hours agoIs this the best ASX ETF to diversify your portfolio with?
-
General12 hours agoLiberals go back to basics after crawling to year’s end
-
Business17 hours ago3 of the best ASX ETFs to build significant wealth
-
General17 hours agoTrolls stole Dr Juliet Turner’s joy and in doing so took their own